However, BMSC treatment in T1DM rats significantly increased vascular inflammatory response identified by increased Angiogenin, MMP9 and ED1 expression as well as increased arteriosclerosis-like vascular structure changes. This evidence concerns the gene MMP9 and type 1 diabetes mellitus.